LifeArc Ventures Scales Global VC Portfolio in Life Sciences
London, United Kingdom | January 29, 2026 — LifeArc Ventures, the venture capital arm of medical research organization LifeArc,...
Biotech Investment
Advertisement
Restart Life Secures Oversubscribed Financing to Advance Growth
Vancouver, British Columbia, December 18, 2025 — Restart Life Sciences Corp., a Canadian-based life sciences company, has successfully closed...
AEON Biopharma Posts Q3 Gains with Strong ABP-450 Biosimilarity Data
IRVINE, CA — November 14, 2025 — AEON Biopharma announced its third-quarter 2025 financial results, highlighting strong operational progress,...
Gate Bioscience Raises $65M to Advance Molecular Gates
BRISBANE, CA – November 13, 2025 — Gate Bioscience announced the closing of an oversubscribed $65 million Series B...
Sanofi Expands Sanofi Ventures With $625M to Drive Biotech Innovation
PARIS, Sept. 24, 2025 — Sanofi announced a $625 million capital expansion for its corporate venture fund, Sanofi Ventures,...
Advertisements
NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a late-clinical stage biotechnology company developing therapies for neurodegenerative diseases, has entered into a...
Advertisement
